SCHEMBL4907412

SCHEMBL4907412

CCN(c1coc(-c2ccc(C(C)(C)C)cc2)n1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 1/20 0.36
TRPM8 Q7Z2W7 2/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 2/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HDAC8 Q9BY41 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
KDM4E B2RXH2 2/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
MAPT P10636 1/20 0.34
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
RXRB P28702 1/20 0.33
KEAP1 Q14145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4911906 0.92 HDAC8 (0.39) TRPM8LMNAALDH1A1HPGDALOX15
SCHEMBL4895724 0.91 PPARG (0.38) HCRTR2ALDH1A1HDAC8HDAC3HDAC11
SCHEMBL4897582 0.90 LMNA (0.40) HCRTR2TRPM8LMNAALDH1A1HPGD
SCHEMBL4899823 0.86 LMNA (0.40) HCRTR2TRPM8LMNAALDH1A1HPGD
SCHEMBL4895934 0.84 LMNA (0.40) HCRTR2TRPM8LMNAALDH1A1HPGD
SCHEMBL4897429 0.83 PPARG (0.39) HCRTR2TRPM8LMNAALDH1A1HPGD
SCHEMBL4906054 0.83 TRPM8 (0.37) HCRTR2TRPM8LMNAALDH1A1HPGD
SCHEMBL4903873 0.83 HDAC8 (0.38) ALDH1A1HDAC8HDAC3HDAC11HDAC6
SCHEMBL4900715 0.83 ALDH1A1 (0.39) HCRTR2LMNAALDH1A1HPGDALOX15
SCHEMBL4906508 0.81 LMNA (0.41) TRPM8LMNAALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HCRTR2 3933/4885TRPM8 4317/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HCRTR2 3933/4885TRPM8 4317/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.